Follow

is a useful antidiabetic substance, but also an endocrine disruptor. A recent study shows that it reduces the set point of homeostasis, but this effect is mitigated by deficiency.

pubmed.ncbi.nlm.nih.gov/392044
doi.org/10.3390/pharmaceutics1

Sign in to participate in the conversation
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.